Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Authors Wani R, Dar M, Chandel R, Rather Y, Haq I, Hussain A, Malla A

Received 23 March 2015

Accepted for publication 23 March 2015

Published 30 March 2015 Volume 2015:11 Pages 863—864

DOI https://doi.org/10.2147/NDT.S85295


Wani RA, Dar MA, Chandel RK, et al
 
Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”. 
 
Read the original paper 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]